Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
42
IVZ Quote, Financials, Valuation and Earnings
Last price:
$26.51
Seasonality move
:
-0.83%
Day range:
$25.71 - $26.57
52-week range:
$11.60 - $29.61
Dividend yield:
3.17%
P/E ratio:
19.44x
P/S ratio:
1.86x
P/B ratio:
0.96x
Volume:
3.8M
Avg. volume:
6.6M
1-year change:
43.97%
Market cap:
$11.8B
Revenue:
$6.4B
EPS (TTM):
-$1.62
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | $5.9B | $5.5B | $6B | $6.4B | |
| Revenue Growth (YoY) | 13.33% | -15.51% | -6.45% | 8.47% | 6.12% | |
| Cost of Revenues | $2.4B | $2.1B | $2B | $2.2B | $2.1B | |
| Gross Profit | $4.7B | $3.8B | $3.5B | $3.8B | $4.3B | |
| Gross Profit Margin | 66.41% | 64.85% | 63.76% | 63.3% | 66.65% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $847.7M | -$30.4M | $178M | $172.3M | -- | |
| Operating Expenses | $2.7B | $2.7B | $2.8B | $3B | $4.9B | |
| Operating Income | $1.9B | $1.1B | $709.5M | $798M | -$695.7M | |
| Net Interest Expenses | $255.4M | $308.4M | $70.5M | $58M | $82.5M | |
| EBT. Incl. Unusual Items | $2.5B | $1.2B | -$237.9M | $1B | -$379.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $531.1M | $322.2M | -$69.7M | $252.9M | -$204.6M | |
| Net Income to Company | $2B | $925.5M | -$168.2M | $752.4M | -- | |
| Minority Interest in Earnings | $339.6M | $4.8M | -$71.3M | -$22.4M | $106.9M | |
| Net Income to Common Excl Extra Items | $2B | $925.5M | -$168.2M | $752.4M | -$174.8M | |
| Basic EPS (Cont. Ops) | $3.01 | $1.49 | -$0.73 | $1.18 | -$1.60 | |
| Diluted EPS (Cont. Ops) | $2.99 | $1.49 | -$0.73 | $1.18 | -$1.60 | |
| Weighted Average Basic Share | $462.8M | $457.5M | $454.8M | $457M | $452.6M | |
| Weighted Average Diluted Share | $465.4M | $459.5M | $454.8M | $457M | $452.6M | |
| EBITDA | $2.2B | $1.3B | $892.3M | $977.6M | -- | |
| EBIT | $1.9B | $1.1B | $709.5M | $798M | -$695.7M | |
| Revenue (Reported) | $7B | $5.9B | $5.5B | $6B | $6.4B | |
| Operating Income (Reported) | $1.9B | $1.1B | $709.5M | $798M | -$695.7M | |
| Operating Income (Adjusted) | $1.9B | $1.1B | $709.5M | $798M | -$695.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $1.4B | $1.5B | $1.7B | |
| Revenue Growth (YoY) | -9.78% | -4.24% | -5.65% | 7.69% | 11.84% | |
| Cost of Revenues | $590.9M | $495.9M | $505.8M | $570.7M | $559.1M | |
| Gross Profit | $964.1M | $993.2M | $899.1M | $942.2M | $1.1B | |
| Gross Profit Margin | 62% | 66.7% | 64% | 62.28% | 66.96% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $232.8M | $158.7M | $137.8M | -$6.5M | -- | |
| Operating Expenses | $810.5M | $690M | $708.2M | $719.4M | $2.6B | |
| Operating Income | $153.6M | $303.2M | $190.9M | $222.8M | -$1.5B | |
| Net Interest Expenses | $63.1M | $95.9M | $16.8M | $12.4M | $23M | |
| EBT. Incl. Unusual Items | $687.8M | $390.4M | -$933.5M | $317.4M | -$1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $130.7M | $89.6M | -$266.4M | $78.7M | -$349.5M | |
| Net Income to Company | $557.1M | $300.8M | -$667.1M | $238.7M | -- | |
| Minority Interest in Earnings | $71.1M | $53.8M | $16M | -$29.8M | $65.2M | |
| Net Income to Common Excl Extra Items | $557.1M | $300.8M | -$667.1M | $238.7M | -$995.9M | |
| Basic EPS (Cont. Ops) | $0.92 | $0.41 | -$1.64 | $0.46 | -$2.63 | |
| Diluted EPS (Cont. Ops) | $0.92 | $0.41 | -$1.64 | $0.46 | -$2.63 | |
| Weighted Average Basic Share | $463.3M | $457M | $451.7M | $453.3M | $451.2M | |
| Weighted Average Diluted Share | $465.6M | $459.1M | $453.1M | $454.1M | $451.2M | |
| EBITDA | $204M | $351.8M | $237.3M | $266.9M | -- | |
| EBIT | $153.6M | $303.2M | $190.9M | $222.8M | -$1.5B | |
| Revenue (Reported) | $1.6B | $1.5B | $1.4B | $1.5B | $1.7B | |
| Operating Income (Reported) | $153.6M | $303.2M | $190.9M | $222.8M | -$1.5B | |
| Operating Income (Adjusted) | $153.6M | $303.2M | $190.9M | $222.8M | -$1.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | $6B | $5.8B | $6B | $6.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.4B | $2.1B | $2B | $2.2B | $2.2B | |
| Gross Profit | $4.7B | $4B | $3.8B | $3.8B | $4.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $847.7M | -$30.4M | $178M | $172.3M | -- | |
| Operating Expenses | $2.7B | $2.5B | $2.8B | $3B | $4.8B | |
| Operating Income | $1.9B | $1.4B | $960.3M | $800M | -$549.3M | |
| Net Interest Expenses | $255.4M | $308.4M | $350.1M | $295.7M | $82.5M | |
| EBT. Incl. Unusual Items | $2.5B | $1.2B | -$237.9M | $1B | -$379.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $531.1M | $322.2M | -$69.7M | $252.9M | -$204.6M | |
| Net Income to Company | $2B | $925.5M | -$168.2M | $752.4M | -- | |
| Minority Interest in Earnings | $339.6M | $4.8M | -$71.3M | -$22.4M | $106.9M | |
| Net Income to Common Excl Extra Items | $2B | $925.5M | -$168.2M | $752.4M | -$174.8M | |
| Basic EPS (Cont. Ops) | $3.01 | $1.49 | -$0.75 | $1.19 | -$1.61 | |
| Diluted EPS (Cont. Ops) | $2.99 | $1.49 | -$0.75 | $1.18 | -$1.62 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.2B | $1.6B | $1.1B | $979.6M | -- | |
| EBIT | $1.9B | $1.4B | $960.3M | $800M | -$549.3M | |
| Revenue (Reported) | $7B | $6B | $5.8B | $6B | $6.5B | |
| Operating Income (Reported) | $1.9B | $1.4B | $960.3M | $800M | -$549.3M | |
| Operating Income (Adjusted) | $1.9B | $1.4B | $960.3M | $800M | -$549.3M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | $5.8B | $6B | $6.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1B | $2B | $2.2B | $2.2B | -- | |
| Gross Profit | $4B | $3.8B | $3.8B | $4.2B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$30.4M | $178M | $172.3M | $139.8M | -- | |
| Operating Expenses | $2.5B | $2.8B | $3B | $4.8B | -- | |
| Operating Income | $1.4B | $960.3M | $800M | -$549.3M | -- | |
| Net Interest Expenses | $308.4M | $350.1M | $295.7M | $82.5M | -- | |
| EBT. Incl. Unusual Items | $1.2B | -$237.9M | $1B | -$379.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $322.2M | -$69.7M | $252.9M | -$204.6M | -- | |
| Net Income to Company | $925.5M | -$168.2M | $752.4M | $821.1M | -- | |
| Minority Interest in Earnings | $4.8M | -$71.3M | -$22.4M | $106.9M | -- | |
| Net Income to Common Excl Extra Items | $925.5M | -$168.2M | $752.4M | -$174.8M | -- | |
| Basic EPS (Cont. Ops) | $1.49 | -$0.75 | $1.19 | -$1.61 | -- | |
| Diluted EPS (Cont. Ops) | $1.49 | -$0.75 | $1.18 | -$1.62 | -- | |
| Weighted Average Basic Share | $1.8B | $1.8B | $1.8B | $1.8B | -- | |
| Weighted Average Diluted Share | $1.8B | $1.8B | $1.8B | $1.8B | -- | |
| EBITDA | $1.6B | $1.1B | $979.6M | $1B | -- | |
| EBIT | $1.4B | $960.3M | $800M | -$549.3M | -- | |
| Revenue (Reported) | $6B | $5.8B | $6B | $6.5B | -- | |
| Operating Income (Reported) | $1.4B | $960.3M | $800M | -$549.3M | -- | |
| Operating Income (Adjusted) | $1.4B | $960.3M | $800M | -$549.3M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.2B | $1.5B | $1.9B | $1.5B | $1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.3B | $1B | $951.6M | $1.1B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.2B | $2.3B | $2.6B | $2.2B | $1B | |
| Property Plant And Equipment | $774.7M | $921.9M | $918.8M | $814.3M | -- | |
| Long-Term Investments | $9.9B | $9.5B | $9.7B | $8.7B | -- | |
| Goodwill | $8.9B | $8.6B | $8.7B | $8.3B | -- | |
| Other Intangibles | $7.2B | $7.1B | $5.8B | $5.7B | -- | |
| Other Long-Term Assets | $2.6B | $1.5B | $1.2B | $1.1B | -- | |
| Total Assets | $32.7B | $29.8B | $28.9B | $27B | $27.1B | |
| Accounts Payable | $39.2M | $59.6M | $31.5M | $30.6M | -- | |
| Accrued Expenses | $655.7M | $606.5M | $567.5M | $584.4M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2B | $1.8B | $1.8B | $1.9B | $3.3B | |
| Long-Term Debt | $9.6B | $8.5B | $9B | $7.5B | $10.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16B | $12.9B | $13B | $11.3B | $14.1B | |
| Common Stock | $113.2M | $113.2M | $113.2M | $113.2M | -- | |
| Other Common Equity Adj | -$441.5M | -$942.4M | -$801.8M | -$1B | -- | |
| Common Equity | $11.5B | $11.2B | $10.6B | $10.5B | $12.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.2B | $1.6B | $1.3B | $1.1B | $773.9M | |
| Total Equity | $16.7B | $16.8B | $15.9B | $15.7B | $13B | |
| Total Liabilities and Equity | $32.7B | $29.8B | $28.9B | $27B | $27.1B | |
| Cash and Short Terms | $2.2B | $1.5B | $1.9B | $1.5B | $1B | |
| Total Debt | $9.6B | $8.5B | $9B | $7.5B | $10.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.2B | $1.5B | $1.9B | $1.5B | $1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.3B | $1B | $951.6M | $1.1B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.2B | $2.3B | $2.6B | $2.2B | $1B | |
| Property Plant And Equipment | $774.7M | $921.9M | $918.8M | $814.3M | -- | |
| Long-Term Investments | $9.9B | $9.5B | $9.7B | $8.7B | -- | |
| Goodwill | $8.9B | $8.6B | $8.7B | $8.3B | -- | |
| Other Intangibles | $7.2B | $7.1B | $5.8B | $5.7B | -- | |
| Other Long-Term Assets | $2.6B | $1.5B | $1.2B | $1.1B | -- | |
| Total Assets | $32.7B | $29.8B | $28.9B | $27B | $27.1B | |
| Accounts Payable | $39.2M | $59.6M | $31.5M | $30.6M | -- | |
| Accrued Expenses | $655.7M | $606.5M | $567.5M | $584.4M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2B | $1.8B | $2.2B | $1.9B | $3.3B | |
| Long-Term Debt | $9.6B | $8.5B | $8.6B | $7.5B | $10.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16B | $12.9B | $13B | $11.3B | $14.1B | |
| Common Stock | $113.2M | $113.2M | $113.2M | $113.2M | -- | |
| Other Common Equity Adj | -$441.5M | -$942.4M | -$801.8M | -$1B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.2B | $1.6B | $1.3B | $1.1B | $773.9M | |
| Total Equity | $16.7B | $16.8B | $15.9B | $15.7B | $13B | |
| Total Liabilities and Equity | $32.7B | $29.8B | $28.9B | $27B | $27.1B | |
| Cash and Short Terms | $2.2B | $1.5B | $1.9B | $1.5B | $1B | |
| Total Debt | $9.6B | $8.5B | $8.6B | $7.5B | $10.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $925.5M | -$168.2M | $752.4M | -- | |
| Depreciation & Amoritzation | $205.3M | $195.3M | $182.8M | $179.6M | -- | |
| Stock-Based Compensation | $140.1M | $106.2M | $114.6M | $104.6M | -- | |
| Change in Accounts Receivable | $5.6B | $912.8M | $448.7M | $319.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.5B | $1.1B | $1.3B | $1.4B | $1.5B | |
| Capital Expenditures | $108.8M | $192.9M | $164.3M | $69.1M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.2B | -$795M | -$249M | -$103.1M | -$974.4M | |
| Dividends Paid (Ex Special Dividend) | $544.5M | $571.6M | $594.7M | $608.3M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.4B | $30.1M | $703M | $3.8B | -- | |
| Long-Term Debt Repaid | -$2.5B | -$605.1M | -$451.8M | -$4.7B | -- | |
| Repurchase of Common Stock | $60.9M | $244.7M | $187.5M | $79.3M | -- | |
| Other Financing Activities | $117.5M | $424.4M | -$54.4M | -$51.1M | -- | |
| Cash From Financing | $117.3M | -$966.9M | -$585.4M | -$1.7B | -$149.5M | |
| Beginning Cash (CF) | $2.1B | $1.4B | $1.9B | $1.5B | $1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $307.8M | -$713M | $497.5M | -$435.6M | $483.8M | |
| Ending Cash (CF) | $2.4B | $647.4M | $2.5B | $1B | $1.6B | |
| Levered Free Cash Flow | $1.3B | $929.7M | $1.1B | $1.3B | $1.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $557.1M | $300.8M | -$667.1M | $238.7M | -- | |
| Depreciation & Amoritzation | $50.4M | $48.6M | $46.4M | $44.1M | -- | |
| Stock-Based Compensation | $34.1M | $23.1M | $20.9M | $14.1M | -- | |
| Change in Accounts Receivable | $329.9M | $190.9M | -$54.8M | -$45.6M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $278.9M | $426.5M | $340M | $303.2M | $534.6M | |
| Capital Expenditures | $35.6M | $73.1M | $40.3M | -$7M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$551.1M | -$100.6M | $112.7M | -$3.2M | -$431M | |
| Dividends Paid (Ex Special Dividend) | $138M | $144.9M | $149.4M | $152M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $659.3M | -$24.2M | $157.9M | $1.5B | -- | |
| Long-Term Debt Repaid | -$525.2M | -$1.2M | -$135.7M | -$1.7B | -- | |
| Repurchase of Common Stock | $2.8M | $4.6M | $4.4M | $26M | -- | |
| Other Financing Activities | $419.2M | $6.8M | $21.3M | -$16.8M | -- | |
| Cash From Financing | $103.1M | -$168.1M | -$110.3M | -$392.5M | $356.1M | |
| Beginning Cash (CF) | $2.1B | $1.4B | $1.9B | $1.5B | $1B | |
| Foreign Exchange Rate Adjustment | -$2M | $154.3M | $34.1M | -$50.9M | -$3.7M | |
| Additions / Reductions | -$171.1M | $312.1M | $376.5M | -$143.4M | $456M | |
| Ending Cash (CF) | $2B | $1.9B | $2.3B | $1.3B | $1.5B | |
| Levered Free Cash Flow | $243.3M | $353.4M | $299.7M | $310.2M | $534.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $925.5M | -$168.2M | $752.4M | -- | |
| Depreciation & Amoritzation | $205.3M | $195.3M | $182.8M | $179.6M | -- | |
| Stock-Based Compensation | $140.1M | $106.2M | $114.6M | $104.6M | -- | |
| Change in Accounts Receivable | $5.6B | $912.8M | $448.7M | $319.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.5B | $1.1B | $1.3B | $1.4B | $1.5B | |
| Capital Expenditures | $108.8M | $192.9M | $164.3M | $69.1M | $60.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.2B | -$795M | -$249M | -$103.1M | -$974.4M | |
| Dividends Paid (Ex Special Dividend) | $544.5M | $571.6M | $594.7M | $608.3M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.4B | $30.1M | $703M | $3.8B | -- | |
| Long-Term Debt Repaid | -$2.5B | -$605.1M | -$451.8M | -$4.7B | -- | |
| Repurchase of Common Stock | $60.9M | $244.7M | $187.5M | $79.3M | -- | |
| Other Financing Activities | $117.5M | $424.4M | -$54.4M | -$51.1M | -- | |
| Cash From Financing | $117.3M | -$966.9M | -$585.4M | -$1.7B | -$149.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $307.8M | -$713M | $497.5M | -$435.6M | $483.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.3B | $929.7M | $1.1B | $1.3B | $1.5B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $925.5M | -$168.2M | $752.4M | $821.1M | -- | |
| Depreciation & Amoritzation | $195.3M | $182.8M | $179.6M | $119.9M | -- | |
| Stock-Based Compensation | $106.2M | $114.6M | $104.6M | $59.8M | -- | |
| Change in Accounts Receivable | $912.8M | $448.7M | $319.7M | -$123.2M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.1B | $1.3B | $1.4B | $1.5B | -- | |
| Capital Expenditures | $192.9M | $164.3M | $69.1M | $60.7M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$795M | -$249M | -$103.1M | -$974.4M | -- | |
| Dividends Paid (Ex Special Dividend) | $571.6M | $594.7M | $608.3M | $442.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $30.1M | $703M | $3.8B | $4.7B | -- | |
| Long-Term Debt Repaid | -$605.1M | -$451.8M | -$4.7B | -$3.4B | -- | |
| Repurchase of Common Stock | $244.7M | $187.5M | $79.3M | $1.2B | -- | |
| Other Financing Activities | $424.4M | -$54.4M | -$51.1M | -$26.1M | -- | |
| Cash From Financing | -$966.9M | -$585.4M | -$1.7B | -$149.5M | -- | |
| Beginning Cash (CF) | $5.4B | $6B | $6.1B | $5.9B | -- | |
| Foreign Exchange Rate Adjustment | -$73.7M | $26.4M | -$32.4M | $82.4M | -- | |
| Additions / Reductions | -$713M | $497.5M | -$435.6M | $483.8M | -- | |
| Ending Cash (CF) | $4.6B | $6.5B | $5.6B | $6.5B | -- | |
| Levered Free Cash Flow | $929.7M | $1.1B | $1.3B | $1.5B | -- | |
Get IVZ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IVZ
Sector
P/E ratio
19.44x
12.49x
PEG ratio
--
0.32x
P/B ratio
0.96x
1.14x
Price / LTM sales
1.86x
1.85x
Growth Metrics
IVZ
Sector
Revenue growth
11.84%
5.46%
Earnings growth
-670.41%
10.33%
Revenue (5-year growth)
0.61%
8.67%
Earnings forecast
$0.58
$0.64
Profitability
IVZ
Sector
Profitability FY 2025
$4.3B
--
Return on invested capital
-0.74%
5.19%
Return on assets
-0.63%
1.03%
Return on equity
-1.18%
9.9%
Earnings Date
Last Earnings Date
Jan
27
Next Earnings Date
Apr
21
Estimated Next Earnings Date
Apr
28
Balance Sheet
IVZ
Sector
Total cash
$1B
$406.5M
Short term investments
--
$190.5M
Total assets
$27.1B
$3.1B
Long term debt
$10.8B
$55.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
